Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-11-01
2005-11-01
Saeed, Kamal (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S377100
Reexamination Certificate
active
06960609
ABSTRACT:
This invention relates to 1-diphenylmethyl-pyrazole derivatives of formula (I):and pharmaceutically acceptable salts thereof; wherein R1, R2, R3, R4and R5are defined herein, as ligands for opioid receptors, particularly the delta opioid receptor. The compounds of the invention have a broad range of therapeutic uses in the area of addictions, analgesia, immunotherapy, shock and brain injuries, neurological dysfunction, gastrointestinal dysfunction, among others.
REFERENCES:
patent: 4118487 (1978-10-01), Regel et al.
patent: WO0014066 (2000-03-01), None
Fang Wang, et al., “Non-Aqueous Capillary Electrophoresis Chiral Separations with Sulfated Beta-Cyclodextrin”, Journal of Chromatography, B: Biiomedical Sciences and Applicaitons (1999). 731(2), pp 187-197, XP004179567 Bifonazole.
Luisa Cerrada, et al., “Azolyl Substituted 1,2 Troeger's Bases”, Journal of the Chemical Society, Chemical Communications (1993), (23), pp 1713-1714, XP002219017.
Inayat A. Bhatti, et al., “Pyrolysis of 1-Substituted Pyrazoles and Chloroform at 550 Degree C: Formation of Alpha-Carboline from 1-Benzylpyrazoles”, Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1997), (24), pp 3581-3585, XP002219018.
Database WPI, Section Ch. Week 198213, Derwent Publications Ltd., London, GB; Class B03, AN 1982-25801E, XP002219019 and SU 883 964 A (Unov Rost), May 30, 1981.
McHardy Stanton F.
Vetelino Michael G.
Pfizer Inc.
Pfizer Products Inc.
Saeed Kamal
Scully Scott Murphy & Presser
LandOfFree
1-diphenylmethyl-pyrazole derivatives as opioid receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-diphenylmethyl-pyrazole derivatives as opioid receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-diphenylmethyl-pyrazole derivatives as opioid receptor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3500861